ERBB2 and glioblastoma: Another clinical study involving 10 consecutive GBM patients highlighted that HER2-specific T cells stimulated the proliferation of T cells and the secretion of interferon‐gamma (IFN‐γ) and IL-2 when interacting with HER2-positive autologous GBM cells [23].